RK
Raju Kucherlapati
Founder of KEW Group
Weston, Massachusetts
Overview
Raju Kucherlapati is a Professor at Harvard Medical School with expertise in cancer, molecular biology, and drug discovery. He has held key roles at prestigious institutions like Brigham and Women's Hospital and has made significant contributions to the biotechnology and pharmaceutical industries through his involvement in companies like AVEO Pharmaceuticals and Millennium Pharmaceuticals.
Work Experience
Professor
2001 - Current
Teaching and research
Professor
2001
research and teaching
Founder and member BOD
2010
Member of the Board of Directors
Professor of Medicine
2001
Teaching and research
Member, Board of Directors
2009 - 2021
Member of the Board of Directors
Metamark Genetics develops prognostic and predictive diagnostic tests that enable personalized treatment planning for cancer patients.
Raised $37,650,000.00 from Perseus.
Member, Board of Directors
2002 - 2021
Member of the Board of Directors
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Raised $560,849,997.00 from Hercules Capital.
Member, BOD
2014 - 2015
Member of the Board of Directors
Member, BOD
2014 - 2015
Member of the Board of Directors
Member, BOD
2014 - 2015
Help set policy
member
2008 - 2015
Member
Member BOD
2008 - 2010
Member of the Board of Directors
Scientific Director
2001 - 2008
Scientific Director. Managing the Center
Member, Board of Directors
1993 - 2008
Member of the Board of Directors.